Internal Medicine Alert – December 30, 2005
December 30, 2005
View Archives Issues
-
Imiquimod — It's Not Just for Genital Warts Anymore
Imiquimod is safe and effective in the treatment of actinic keratoses. -
Make Mine Espresso!
Cola consumption, but not caffeine per se, was associated with increased risk of developing hypertension over a 12-year period. -
CABG vs Stenting: Which is Better?
A meta-analysis comparing percutaneous balloon angioplasty alone vs coronary artery bypass grafting (CABG) demonstrated no significant differences in mortality and nonfatal myocardial infarction (MI) however, a statistically significant benefit in terms of survival in favor of surgery1 was noted. -
Exanatide: The New Shot for Diabetes
A new injectable diabetes medication in the family of incretin mimetic drugs has been shown to be as effective as insulin in controlling average blood sugars in Type 2 diabetics who are difficult to control on oral medications, without as much associated weight gain. -
Pharmacology Update: Tipranavir Capsules (Aptivus®)
Tipranavir is a recently approved protease inhibitor for the treatment of HIV-1 infections. It is a selective non-peptide HIV-1 protease inhibitor for treatment-experienced adults with resistance to multiple protease inhibitors. Tipranavir is marketed by Boehringer Ingelheim as Aptivus®. -
Clinical Briefs By Louis Kuritzky, MD
Doxycycline Hyclate 20 mg Tablets and Metronidazole 0.75% Topical Lotion in the Treatment of Rosacea; Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation; Comorbid Depression with Mortality in Patients with DM